Injective (INJ) is currently experiencing a strong upward trend, as evidenced by the MACD histogram reading of 0.1623. Analyst forecasts for the stock vary widely, with some predicting a target price of $15 while others anticipate a price as high as $51. Despite this discrepancy, the prevailing sentiment is that the price of INJ could reach $18-20 by October 2025.